MindWalk Holdings (HYFT) Asset Writedowns and Impairment (2020 - 2025)

MindWalk Holdings (HYFT) reported Asset Writedowns and Impairment of $2719.6 for Q2 2025, down 99.9% year-over-year from $2.9 million in Q2 2024, and down 99.9% quarter-over-quarter from $2.9 million in Q2 2024.

MindWalk Holdings (HYFT) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends

MindWalk Holdings (HYFT) has 5 years of Asset Writedowns and Impairment data on file, last reported at $2719.6 in Q2 2025.

  • Asset Writedowns and Impairment for Q2 2025 came in at $2719.6, down 99.9% year-over-year; the trailing twelve-month figure through Apr 2025 was $3.0 million (changed 0.09% YoY), and the FY2025 annual result was $15.2 billion, up 532718.52% from the prior year.
  • Asset Writedowns and Impairment eased to $2719.6 in Q2 2025 per HYFT's latest filing, from $2.9 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $2.9 million in Q2 2024 and troughed at -$34307.3 in Q2 2021.
  • A 4-year average of $327829.0 and a median of $2.33 in 2022 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment surged 483.95% in 2022, then tumbled 99.9% in 2025.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$16.7 in 2021, then surged by 113.96% to $2.33 in 2022, then surged by 122362339.1% to $2.9 million in 2024, then sank by 99.9% to $2719.6 in 2025.
  • Business Quant data shows HYFT's Asset Writedowns and Impairment at $2719.6 in Q2 2025, $2.9 million in Q2 2024, and $2.33 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78

Historic Data

Download Data
DateValue
Apr 30, 2025 2,719.56
Apr 30, 2025 2,719.56
Apr 30, 2024 2.85 Mn
Apr 30, 2024 2.85 Mn
Jul 31, 2022 2.33
Jul 31, 2022 2.33
Apr 30, 2022 131,723.85
Apr 30, 2022 131,723.85
Jan 31, 2022 131.94
Jan 31, 2022 131.94
Oct 31, 2021 -16.70
Oct 31, 2021 -16.70
Jul 31, 2021 -2,441.95
Jul 31, 2021 -2,441.95
Apr 30, 2021 -34,307.30
Apr 30, 2021 -34,307.30
Jan 31, 2021 -1,554.60
Jan 31, 2021 -1,554.60
Oct 31, 2020 -3,781.65
Oct 31, 2020 -3,781.65